Acute Bacterial Bronchitis
Learn about Acute Bacterial Bronchitis, also known as Bacterial Bronchitis or Acute Infectious Bronchitis. This page provides information on diagnosis, clinical documentation, and medical coding for healthcare professionals. Find details on symptoms, treatment, and management of Acute Bacterial Bronchitis for accurate and efficient clinical practice and documentation.
Short-term bacterial lung infection affecting the bronchi, causing inflammation and mucus.
Cough (wet or dry), shortness of breath, chest discomfort, fever, fatigue.
Outpatient clinic, urgent care, telehealth, occasionally hospital for severe cases.
ICD-10 Code Families
Complete code families applicable to J20.8
When to use each related code
| Description | When to use |
|---|---|
| Sudden bacterial lung infection in the airways. | Acute bronchitis symptoms with bacterial cause suspected. Consider after antibiotics started. |
| Inflammation of the bronchi, often viral. | Cough, chest tightness, and shortness of breath. Typically follows a viral infection. Acute, self-limiting. |
| Long-term inflammation and mucus in bronchi. | Chronic productive cough, often in smokers. Exclude other causes like asthma or COPD. |
Best-practice checklist
- ✓Document symptom onset and duration.
- ✓Describe cough characteristics (e.g., productive, dry).
- ✓Note auscultatory findings (e.g., wheezing, rhonchi).
- ✓Record patient temperature and respiratory rate.
- ✓Specify antibiotic treatment and rationale if given.
Common pitfalls to avoid
Coding acute bacterial bronchitis without specifying the causative organism can lead to rejected claims or lower reimbursement.
Misdiagnosing viral bronchitis as bacterial can lead to inappropriate antibiotic prescriptions and inaccurate coding.
Insufficient documentation of symptoms and diagnostic testing can lead to coding and billing errors, triggering audits.
Best-practice tips
- 01Document symptom duration for accurate J20.x coding.
- 02Confirm bacterial etiology with cultures for CDI.
- 03Antibiotic stewardship: Target therapy based on C&S.
- 04Ensure proper ICD-10-CM, J20.9 vs. J40, for compliance.
- 05Monitor patient response and document for improved outcomes.
Step-by-step checklist
- 1
Confirm cough >5 days AND no other cause (ICD-10 J20.9)
- 2
Rule out pneumonia: auscultate for localized findings, CXR if indicated
- 3
Assess for fever, purulent sputum: suggestive of bacterial infection
- 4
Document symptom duration, severity, and response to prior therapy
Ready-to-paste narrative
Patient presents with symptoms consistent with acute bacterial bronchitis, also known as bacterial bronchitis or acute infectious bronchitis. The patient reports a productive cough with thick mucus, chest discomfort, and shortness of breath. Symptoms onset was approximately one week ago, initially presenting as a common cold with rhinorrhea and mild cough. The cough has progressively worsened, becoming productive with purulent sputum. Patient denies fever, chills, or night sweats. Lung auscultation reveals diffuse wheezing and rhonchi. No signs of consolidation or pleural effusion are noted. Differential diagnoses considered include viral bronchitis, pneumonia, and asthma exacerbation. Given the presentation of purulent sputum and the progression of symptoms, acute bacterial bronchitis is the most likely diagnosis. Treatment plan includes a course of antibiotics, such as amoxicillin or doxycycline, along with bronchodilators for symptomatic relief of wheezing and cough. Patient education provided on proper antibiotic use, hydration, and cough hygiene. Follow-up scheduled in one week to assess response to treatment. ICD-10 code J20.9, acute bronchitis, unspecified, is assigned. Medical billing codes will reflect the evaluation and management service provided, along with codes for prescribed medications and any diagnostic tests performed.
Common questions and answers
How to differentiate acute bacterial bronchitis from viral bronchitis in pediatric patients with persistent cough?+
Differentiating acute bacterial bronchitis (ABB) from viral bronchitis in children with a persistent cough can be challenging due to overlapping symptoms. While both present with cough, ABB often involves a productive cough with purulent sputum, possibly accompanied by fever and elevated inflammatory markers like CRP and procalcitonin. Viral bronchitis typically presents with a dry or minimally productive cough alongside other viral symptoms like rhinorrhea or sore throat. However, these distinctions are not always clear-cut. Consider auscultating for focal crackles or wheezing which may suggest ABB, though these findings can be present in viral bronchitis as well. Chest X-rays are generally not recommended for uncomplicated bronchitis but may be considered in cases of severe illness or diagnostic uncertainty to exclude pneumonia. Explore how implementing a validated clinical prediction rule, such as the one developed by Harris et al. (2017), can aid in distinguishing ABB from viral bronchitis and guide antibiotic prescribing decisions in children. Learn more about the importance of judicious antibiotic use to minimize the risk of antibiotic resistance.
What are the evidence-based antibiotic treatment recommendations for confirmed acute bacterial bronchitis in adults?+
Antibiotic treatment for confirmed acute bacterial bronchitis (ABB) in adults should be guided by local resistance patterns and patient-specific factors. First-line therapy typically involves amoxicillin or doxycycline. For patients with penicillin allergies, macrolides like azithromycin or clarithromycin may be considered, though increasing macrolide resistance necessitates careful consideration. In cases of suspected or confirmed atypical pathogens like Mycoplasma pneumoniae or Chlamydia pneumoniae, a respiratory fluoroquinolone (e.g., levofloxacin or moxifloxacin) or a tetracycline (e.g., doxycycline) may be appropriate. Treatment duration typically ranges from 5 to 7 days for most cases of ABB, but longer courses may be necessary for specific pathogens or complicated presentations. Consider implementing guidelines from reputable sources like the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) for managing adult ABB. Explore how antibiotic stewardship programs can help optimize antibiotic prescribing practices and reduce the emergence of antibiotic resistance.
When to suspect acute bacterial bronchitis as a complication of a viral upper respiratory infection and how to manage it?+
Acute bacterial bronchitis (ABB) can sometimes complicate a viral upper respiratory infection (URI). Suspect ABB if a patient with an initial viral URI experiences worsening symptoms such as increased cough severity, change in sputum characteristics (becoming purulent), or new-onset fever after initial improvement. Persistent or recurrent fever beyond the typical duration of a viral URI should also raise suspicion for secondary bacterial infection. Thorough clinical evaluation, including auscultation and assessment of inflammatory markers, is crucial. While chest radiography is generally not recommended for uncomplicated bronchitis, it may be considered in cases of severe illness or suspected pneumonia. Management of ABB following a viral URI is similar to the management of primary ABB and involves antibiotic therapy as described above, guided by patient-specific factors and local resistance patterns. Consider implementing a watchful waiting approach in patients with mild symptoms and close follow-up to monitor for disease progression. Learn more about the potential complications of untreated ABB and the importance of prompt and appropriate management.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.